fda semaglutide warning november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs FDA Sends Warning Letters to

If you have reduced kidney function, protein targets should be determined by your nephrologist, and standard keto protein recommendations may need downward adjustment

These drugs mimic GLP-1 the hormone the body naturally produces after eating to make people feel full, reducing their cravings

Fortified foods offer another option

GLP-1s are given by injection and include such drugs as semaglutide, which has been used for more than 15 years to regular blood sugar in diabetes and is the active ingredient in the popular weight loss drugs Wegovy and Ozempic

It is not explicitly marketed for weight loss but may have synergistic properties that can influence weight management